Aflibercept in Polypoidal Choroidal Vasculopathy

Clinical trial NCT02120950 · COMPLETED

Trial details

NCT number: NCT02120950
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Neovascular Macular Degeneration

Start date: 2014-05-29
Primary completion: 2016-08-12
Enrollment: 333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.